Key result
Na+/H+ exchange inhibition with EIPA improves post-ischemic LV developed pressure recovery ~3-fold in rat hearts.
Answers are grounded in this paper and cite their sources.
Interleaved 23Na- and 31P-nuclear magnetic resonance (NMR) spectra were continuously collected on perfused rat hearts subjected to low-flow ischemia (30 min, 10% flow) or zero-flow ischemia (21 min) followed by reperfusion. During untreated low-flow and zero-flow ischemia, intracellular Na+ (Nai+) increased by 53 +/- 11 (+/- SE) and 78 +/- 8%, respectively, and remained elevated for zero-flow hearts. However, during both low- and zero-flow ischemia, Nai+ did not increase in hearts treated with the Na(+)-H+ exchange inhibitor, 5-(N-ethyl-N-isopropyl)amiloride (EIPA). The pH decreases during ischemia were unchanged. EIPA treatment reduced ATP depletion during ischemia. During reperfusion from zero-flow ischemia, EIPA-treated hearts displayed more rapid and extensive recoveries of phosphocreatine and ATP. Recovery of left ventricular developed pressure was improved for zero-flow hearts treated with EIPA during the ischemic period exclusively (104 +/- 13%) compared with untreated hearts (36 +/- 21%). These data indicate that Na(+)-H+ exchange is an important mechanism for Nai+ accumulation, but not for pH regulation, during myocardial ischemia. Additionally, Nai+ homeostasis plays an important role in the postischemic recovery of cellular energy and ventricular function.
No takes yet. Share an insight, caveat, or question.
Pike et al. (1993) studied Myocardial ischemia. 5-(N-ethyl-N-isopropyl)amiloride (EIPA) vs. Untreated hearts was evaluated on Recovery of left ventricular developed pressure for zero-flow hearts. Treatment with the Na(+)-H+ exchange inhibitor EIPA improved recovery of left ventricular developed pressure following zero-flow ischemia in perfused rat hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: